Contact
Print
CNS
PSI is a leading full-service CRO operating globally.
98% of PSI-managed clinical trials complete patient enrollment on or ahead of schedule.
PSI's exceptional repeat and referral business rate distinguishes PSI in the market place as a "no-nonsense" CRO that delivers across trials of all sizes and levels of complexity.
PSI has successfully performed Phase II/III studies in the following CNS indications:
- Alzheimer's disease
- CVD (including TIA and stroke)
- Depression
- Diabetic neuropathy
- Epilepsy
- Generalized anxiety disorder
- Insomnia
- Narcolepsy
- Multiple sclerosis
- Opioid dependence
- Parkinson's disease
- Post-stroke spasticity
- Schizophrenia
- Sexual dysfunction
- Smoking cessation
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including neurologists, psychiatrists, and paediatric psychiatrists.